Melix
Melix is a medicine authorised by Swissmedic under authorisation number 44714. The authorisation holder is Lagap SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 24 November 1982 and the authorisation is valid without a time limit. ATC code A10BB01 places the medicine in the group Drugs used in diabetes.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Melix, compresse | B | 24 November 1982 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 19 | 30 | Tablette(n) | A10BB01 | 07.06.2. | B |
| 27 | 100 | Tablette(n) | A10BB01 | 07.06.2. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Melix authorised in Switzerland?
Yes. Melix is authorised by Swissmedic under authorisation number 44714, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Melix have?
Melix is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Melix?
The authorisation holder is Lagap SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.